Question to the Home Office:

To ask the Secretary of State for the Home Department, if she will make an assessment of the potential merits of asking the Advisory Council on the Misuse of Drugs to review their scheduling of Psilocybin.

Psilocybin is controlled under the Misuse of Drugs Act 1971 (‘the 1971 Act’) and placed in Schedule 1 to the Misuse of Drugs Regulations 2001 (‘the 2001 Regulations’). Drugs are typically placed in Schedule 1 when there is no established medical use in the UK.

Ministers are under a duty to consider advice from the Advisory Council on the Misuse of Drugs (ACMD) prior to making regulations under the 1971 Act. The Government has no current plans to commission the ACMD to review the scheduling of psilocybin.

Medicines based on psilocybin have to date not been assessed on the basis of their safety, quality and efficacy and granted a marketing authorisation by the Medicines and Healthcare products Regulatory Authority (MHRA). Reconsideration of scheduling under the 1971 Act would ordinarily follow such an assessment by the MHRA.